NHLBI Clinical Trial Pilot Studies (R34) |
The summary for the NHLBI Clinical Trial Pilot Studies (R34) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.
-
Federal Grant Title: NHLBI Clinical Trial Pilot Studies (R34) CFDA Number: 93.233 CFDA Description: National Center on Sleep Disorders Research Federal Agency Name: National Institutes of Health Category of Funding Activity: Health Category Explanation: Information not provided Opportunity Category: Discretionary Funding Opportunity Number: PAR-10-005 Document Type: Grants Notice Funding Instrument Type: Grant Posted Date: Oct 02, 2009 Creation Date: Oct 02, 2009 Original Closing Date for Applications: Jan 07, 2013 Current Closing Date for Applications: Jan 07, 2013 Archive Date: Feb 07, 2013 Expected Number of Awards: Information not provided Estimated Total Program Funding: $450,000 Federal Grant Award Ceiling: $225,000 Federal Grant Award Floor: Information not provided Cost Sharing or Matching Requirement: No
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Grant Description
- Purpose. The National Heart, Lung, and Blood Institute (NHLBI) (http://www.nhlbi.nih.gov) invites applications proposing pilot studies to obtain data that is critical for the design of robust clinical trials.This Funding Opportunity Announcement (FOA) should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial.Appropriate pilot studies might demonstrate feasibility of an intervention or an experimental design, estimate intervention parameters, or gather other data important for the design of a trial.Applicants who propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial will not be considered appropriate for to this announcement.Applications must demonstrate that the proposed pilot studies are both necessary and sufficient to permit the design of the clinical trial.During the evaluation of applications in response to this FOA, the review group will also consider the significance and potential public health impact of the full-scale clinical trial that would be proposed following the R34 award period.The NHLBI anticipates that the R34 award period will yield more competitive investigator-initiated clinical trial grant applications and more robust and successful clinical trials that evaluate interventions for the treatment or prevention of heart, lung, blood, or sleep disorders. Mechanism of Support. This FOA will utilize the R34 grant mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
- Link to Full Grant Announcement
-
http://grants.nih.gov/grants/guide/pa-files/par-10-005.html
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV] - Similar Government Grants
- • Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R01)
- • Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R21)
- • Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R43/R44)
- • Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R41/R42)
- • The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21)
- • Ancillary Studies in Clinical Trials (R01)
- • Opportunity PA-08-021
- • Research Demonstration and Dissemination Grants (R18)
- • Right Heart Function in Health and Chronic Lung Diseases: (R01)
- • Elucidating Nature s Solutions to Heart, Lung, and Blood Diseases and Sleep Disorder Processes (R01)
